These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10219100)

  • 1. Synthetic strategies and medicinal properties of beta-lactams.
    Kidwai M; Sapra P; Bhushan KR
    Curr Med Chem; 1999 Mar; 6(3):195-215. PubMed ID: 10219100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.
    Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S
    ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors.
    Carosso S; Miller MJ
    Bioorg Med Chem; 2015 Sep; 23(18):6138-47. PubMed ID: 26321604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam.
    Singh GS
    Mini Rev Med Chem; 2004 Jan; 4(1):93-109. PubMed ID: 14754446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria.
    Decuyper L; Deketelaere S; Vanparys L; Jukič M; Sosič I; Sauvage E; Amoroso AM; Verlaine O; Joris B; Gobec S; D'hooghe M
    Chemistry; 2018 Oct; 24(57):15254-15266. PubMed ID: 29882610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
    Long DD; Aggen JB; Chinn J; Choi SK; Christensen BG; Fatheree PR; Green D; Hegde SS; Judice JK; Kaniga K; Krause KM; Leadbetter M; Linsell MS; Marquess DG; Moran EJ; Nodwell MB; Pace JL; Trapp SG; Turner SD
    J Antibiot (Tokyo); 2008 Oct; 61(10):603-14. PubMed ID: 19168974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of AM-112 and related oxapenem analogues.
    Simpson IN; Urch CJ; Hagen G; Albrecht R; Sprinkart B; Pfaendler HR
    J Antibiot (Tokyo); 2003 Oct; 56(10):838-47. PubMed ID: 14700277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactams as versatile synthetic intermediates for the preparation of heterocycles of biological interest.
    Alcaide B; Almendros P
    Curr Med Chem; 2004 Jul; 11(14):1921-49. PubMed ID: 15279574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trimer of phenoxymethyl penicillin sulphone: synthesis of a new beta-lactam podand.
    Agócs A; Herczegh P; Sztaricskai F; Gál Z; Hernádi F
    J Antibiot (Tokyo); 2002 May; 55(5):524-7. PubMed ID: 12139024
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Actions and resistance mechanisms of beta-lactam antibiotics. Penicillin-binding proteins, beta-3-lactamases and signal proteins].
    Heisig P
    Pharm Unserer Zeit; 2006; 35(5):400-8. PubMed ID: 17009783
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming resistance to β-lactam antibiotics.
    Worthington RJ; Melander C
    J Org Chem; 2013 May; 78(9):4207-13. PubMed ID: 23530949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.